Skip to Content

20/25 Logo 5032 (Hydrochlorothiazide and Lisinopril 25 mg / 20 mg)

Pill with imprint 20/25 Logo 5032 is Orange, Round and has been identified as Hydrochlorothiazide and Lisinopril 25 mg / 20 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 25 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 20/25 Logo 5032

Hydrochlorothiazide and lisinopril 25 mg / 20 mg 20/25 Logo 5032
Hydrochlorothiazide and lisinopril 25 mg / 20 mg 20/25 Logo 5032
Hydrochlorothiazide and lisinopril 25 mg / 20 mg 20/25 Logo 5032

Hydrochlorothiazide and Lisinopril

Imprint
20/25 Logo 5032
Strength
25 mg / 20 mg
Color
Orange
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
ACE inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
calcium phosphate dibasic anhydrous, magnesium stearate, mannitol, corn starch, magnesium silicate, FD&C Yellow No. 6, aluminum oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00172-5032 Ivax Pharmaceuticals, Inc.
43063-0130 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.